← All trials
NCT02363322
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 11, 2015
- Primary completion
- Dec 31, 2017
- Completion date
- Dec 31, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 1
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)Overall official - principal investigator
- Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
- Government of Sierra LeoneCollaborator
- Government of LiberiaCollaborator
- Government of the Republic of GuineaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.